Institutional Ethics Committee (IEC) of Government Medical College (GMC) Jammu organized CME cum training on Good Clinical ...

Google Cloud has announced native support for the OpenTelemetry Protocol (OTLP) in its Cloud Trace service, marking a ...

Cancer scientists have been working against the clock for decades to outsmart a disease that comes back more powerfully after ...

A new trial assessing the ability of COYA 302 to slow the progression of ALS will enroll up to 120 patients at sites in the U ...

An expert discusses emerging frontline treatments for EGFR-mutated non–small cell lung cancer (NSCLC), highlighting the ...

Amgen Inc.'s healthy commercial product portfolio and pipeline position the company well for long-term value creation. Read ...

Program will include an update on the Company’s lead asset, lanifibranor, ahead of anticipated Phase 3 NATiV3 topline results ...

Discussion of the use of AI in the drug development space. Sagimet plans to share how it is employing state-of-the-art AI-based digital pathology platforms to complement conventional biopsy approaches ...

Vor Biopharma has rebounded from near-delisting by securing global rights (ex-China) to telitacicept, a promising autoimmune therapy. Click here to read more.

Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company recently completed a ...